My research focuses on health insurance benefit design, healthcare regulations, insurance markets, pharmaceutical use, and medical technology diffusion. My research has been published in leading economics, medical and health policy journals including the Journal of Political Economy, Journal of Risk and Insurance, Journal of Health Economics, Journal of the American Medical Association (JAMA), British Medical Journal, Health Services Research and Health Affairs. Her research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), The U.S. Department of Health and Human Services, Health Resources and Services Administration, and the Robert Wood Johnson Foundation. I was the recipient of a career grant from NIH through which I have been building a research agenda focused on understanding the mechanisms underlying the diffusion of new medical technologies. I am currently the Principal Investigator on NIH and AHRQ funded projects to study uptake of clinical evidence by providers focusing on de-adoption of treatments that are shown to be ineffective or harmful. I am also the Principal Investigator on a new project funded by the American Cancer Society Funded to study uptake of biosimilar drugs in the U.S. markets.